Keyphrases
AIDS/HIV
100%
Anti-HCV
20%
Antiviral Drug Combinations
20%
CD4 Count
20%
Cirrhosis
20%
Co-infected Patients
60%
Continuum of Care
100%
Daclatasvir
100%
Direct-acting Antiviral Drugs
60%
Drug Program
20%
Experience of Care
100%
HCV RNA
60%
HCV Treatment
40%
Hepatitis C
100%
Hepatitis C Treatment
100%
HIV Care
20%
HIV Clinics
20%
HIV Patients
20%
HIV-HCV
60%
Indonesia
100%
Infected Patients
20%
Intravenous Drug Users
20%
Jakarta
20%
Multivariate Analysis
20%
Retrospective Cohort Study
20%
Ribavirin
20%
RNA Test
20%
Sofosbuvir
100%
SVR12
60%
Therapeutic Evaluation
20%
Treatment Completion
20%
Treatment Failure
60%
Type 1 Diabetes Mellitus (T1DM)
60%
Medicine and Dentistry
Antivirus Agent
33%
Cell Count
11%
Combination Drug
11%
Daclatasvir
55%
Diabetes Mellitus
33%
Hepatitis C
100%
Hepatitis C Treatment
100%
Human Immunodeficiency Virus
100%
Liver Cirrhosis
11%
Multivariate Analysis
11%
Retrospective Cohort Study
11%
Ribavirin
11%
Sofosbuvir
55%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
33%
Cohort Study
11%
Combination Drug
11%
Daclatasvir
55%
Diabetes Mellitus
33%
Hepatitis C
100%
HIV
100%
Liver Cirrhosis
11%
Ribavirin
11%
Sofosbuvir
55%
Neuroscience
Antiviral Drug
33%
CD4
11%
Combination Drug
11%
Daclatasvir
55%
Diabetes Mellitus
33%
Hepatitis C
100%
Human Immunodeficiency Virus
100%
Ribavirin
11%
Sofosbuvir
55%